Puestos
330As I mentioned a while ago, I am looking for positions to make my portfolio more price stable. Therefore, today I took position in:
In the more risky corner I find $TWEKA (-0,3 %) a company that has plenty of potential despite disappointing quarters. Picked up at €34 each.
Delivering strong growth, margin expansion, and cash flow with a focused, standalone strategy.
Key investment highlights
- Ice cream market is large, growing at 3-4% CAGR, and offers attractive returns compared to other snacking categories.
- Holds #1 global market share with €7.9bn revenue and €1.3bn Adj. EBITDA in 2024, and four of the five largest brands.
- Portfolio is positioned for growth, leveraging strong brands, innovation, and a broad emerging market footprint.
- Clear strategy focuses on growth, productivity, and reinvestment, with a €500m productivity program underway.
- Revamped front-line organization and incentive alignment drive accountability and profitable growth.
Market and business overview
- Global ice cream market reached €75bn in 2024, expected to grow to €90bn by 2029, with premium segments outpacing mainstream.
- Digital commerce is a key growth driver, projected at 9% CAGR from 2024-2029.
- Emerging markets offer significant upside, with outlet density and per capita consumption below developed markets.
- The business operates through At-Home, Away-from-Home, and dCom channels, leading in each.
- Resilient to GLP-1 impact, with product innovation tailored to evolving consumer health trends.
Regional performance and strategy
- Americas: #1 market position, strong brand portfolio, and innovation drive volume and share growth; cost base reset and digital expansion underway.
- Europe & ANZ: Market is resilient but faced recent challenges; turnaround strategy focuses on portfolio innovation, productivity, and digital-led demand creation.
- AMEA: Fastest-growing and most profitable region, with strategy centered on format innovation, digitalization, and cabinet expansion.
Financial guidance and outlook
- Medium-term targets (from 2026): 3-5% average annual organic sales growth, 40-60bps annual Adj. EBITDA margin improvement, and €0.8bn-€1bn free cash flow in 2028-2029.
- Capex to rise to 4-5% of revenue, with increased investment in innovation, capacity, and digital infrastructure.
- Balanced capital allocation policy includes a 40-60% dividend payout ratio and potential for bolt-on M&A.
- Separation from Unilever on track, with most one-off costs recognized by end of 2026 and full operational independence by 2027.
Strategic transformation and culture
- Standalone structure enables focused capital allocation, tailored operating model, and dedicated leadership.
- Productivity initiatives target €500m in savings, with supply chain, overhead, and technology transformation.
- Culture emphasizes innovation, accountability, and a winning, fun environment, with high employee engagement and positive business outlook.
Hab mir jetzt die ganze Präsentation angeschaut und muss sagen das Unternehmen sieht gar nicht so schlecht aus. Spannend wird es auf jeden Fall. Das Management wirkt auch sehr charismatisch und gut vorbereitet auf den Spin off. $ULVR (+0,22 %) Bin gespannt wie es in einem Jahr aussehen wird.
Another short weekly update with purchase.
#dividend
#dividends
#dividende
#etf
#invest
#investing
#etfs
Today I invested in $MDLZ (-0,45 %) .
Bought 5 shares at an average price of €53,56 per share including transaction costs.
In total I now own 21.659 shares, this gives me +- €31,772 per year in dividend.
The Kikkoman $2801 (-1,64 %) share seems too interesting at the moment not to share my thoughts with you 🙂
I haven't looked at the consumer goods sector, but none of the big standard stocks seem particularly interesting to me ($NESN (-0,97 %) , $ULVR (+0,22 %) , etc.).
In addition, due to the exchange rate, I'm currently looking more closely at Japanese companies and have stumbled across Kikkoman.
Fundamental aspect:
Over the past 15 years, Kikkoman's P/E ratio has averaged over 30.
We are currently at around 21, which is well below the historical average.
Kikkoman has achieved average annual earnings growth of over 15% over the past ten years. Despite the current challenges posed by inflation and supply chain issues, the company has been able to further increase its profits, although a slowdown in profit growth is becoming apparent, which is probably also triggering the current correction.
Chart "Analysis
(I am definitely not a profit wheeler, so please forgive me if this is too simplistic😅)
From a technical point of view, the share has undergone a correction in recent months and is approaching a crucial support zone. The area around the 1300 yen mark (high - September 2018) has repeatedly served as strong support in the past (March 2021, June 2022, March 2023).
I think that a reversal at this support will take place this time as well.
Exchange rate
Another positive factor is the current favorable exchange rate between the euro and the yen. The yen is historically weak against the euro, which makes purchases of Japanese equities comparatively favorable for European investors.
I hope you enjoyed this brief assessment of $2801 (-1,64 %) and perhaps, like me, you have become aware of a great company that has so far received less attention, at least on this platform.
Sources:
Data and graphics from
https://aktienfinder.net/aktien-profil/Kikkoman-Aktie
and exchange rate from Google
+ 1
🌍 Un gigante global
Uinilever ($ULVR) (+0,22 %) es uno de los mayores grupos de consumo del mundo, presente en más de 190 países y con un portafolio de más de 400 marcas. Desde productos de cuidado personal como Dove o Axe, hasta alimentación con Knorr, Hellmann’s y Ben & Jerry’s, la compañía está integrada en la vida diaria de millones de personas.
En un entorno de incertidumbre económica, las empresas de consumo defensivo como Unilever destacan por su resiliencia: la demanda de alimentos, limpieza y cuidado personal se mantiene estable incluso en ciclos de recesión.
📈 Resultados recientes
En sus últimos informes, Unilever mostró:
La estrategia de rotación de portafolio —centrándose en categorías de mayor margen como belleza, salud y nutrición— refuerza su capacidad de generar valor sostenido.
💵 Dividendo y estabilidad
Uno de los mayores atractivos de Unilever es su historial de dividendos. La compañía reparte de forma constante en torno al 3–4 % anual, con un payout sostenible. Para el inversor de largo plazo, esto significa flujo de caja predecible y resiliencia incluso en épocas de volatilidad.
🔮 Mirada a 10 años
De aquí a 2035, Unilever tiene varios motores de crecimiento:
✅ Conclusión
Invertir en Unilever es apostar por un negocio sólido, defensivo y con capacidad de adaptarse a las nuevas tendencias de consumo. No es una acción “espectacular” en revalorización rápida, pero sí una pieza estratégica en cualquier cartera equilibrada: estabilidad, dividendo y proyección global.
Hello my dears,
Here is a great interview for you with Frosta boss Felix Ahlers. I personally see a good corporate philosophy here, which I find more convincing than that of the big players like
$ULVR (+0,22 %) Unilever, $NESN (-0,97 %) Nestlé etc.
"Frosta is there for everyone"
Felix Ahlers, the head of frozen food supplier Frosta, is annoyed by the lack of information in ready-made products and would like to see stricter laws.
18.08.25, 05:00
There is no canteen in the Hamburg office of frozen food supplier Frosta. Instead, all they need is a kitchen and a large freezer - stocked with ready meals from the company, which is based in Bremerhaven. Chef Felix Ahlers is also able to carry out regular quality checks during his lunch break.
In an interview with Funke Mediengruppe (in which KURIER holds a stake), he gives an insight into the company's strategy and explains why people should focus on cooking and eating again.
Dear readers, you can find the interview under the link.
https://kurier.at/wirtschaft/frosta-tiefkuehl-produkte-felix-ahlers-kochen/403074375
I always buy on Friday, because mostly de stocks are at their lowest on that time. With 10 $ULVR (+0,22 %) and 15 $AD (-0,67 %) I have all the groceries for the weekend in my pocket. 😁
With these stocks I add another €35,55 dividend/year on the pile, so the total is well above €1.500,- /year now with a portfolio of €25,5k [6% av]. This must leave something after income taxes. 🤔
How would you deal with the Unilever $ULVR (+0,22 %) position? I have more or less 50 shares in my portfolio since the beginning but somehow I think that the money would be better placed elsewhere... My equity is 49.94€, which results in a performance of ~2.8% (without dividends) or ~11.5% (with dividends).
Same with Pfizer $PFE (-1,12 %) ~-9% incl. dividends, but somehow little to no recovery despite historically good equity.
Thanks for tips
Principales creadores de la semana
